food

Recombinant Factor IX (Alprolix) Brings Hope for Hemophilia B Patients

By: Benedette Cuffari, BS Toxicology Candidate c/o 2015 - Hemophilia B is an inherited bleeding disorder that is caused by…

12 years ago

FDA Defends Generic Drug Labeling Plan

By: Nancy Simon, PharmD c/o 2016 - Last November, the Food and Drug Administration (FDA) submitted a proposal for a…

12 years ago

FDA-Approved Afrezza: An Inhaled Alternative to Injectable Insulin?

By: Elissa Tam, PharmD Candidate c/o 2015 - Patients with Type 1 or Type 2 diabetes who cannot control their…

12 years ago

Combating Counterfeit Drugs

By: Azia Tariq, Staff Editor - With the sale of counterfeit drugs reaching an alarmingly higher rate than ever, The…

12 years ago

An Interview with an FDA Preceptor: Pharmacist’s Role at the FDA

By: Melissa Roy Co-Copy Editor [Graphics focused] - Our dedicated preceptor Kimberly Defronzo, RPh, MS, MBA is currently a Consumer…

12 years ago

Celiac Disease: Seeking Proper Treatment

By: Sang Hyo Kim, Staff Editor - The Mayo Clinic reported in the American Journal of Gastroenterology that 1.8 million…

12 years ago

The Importance of the Measles Vaccine: Should We Be Vaccinated?

By: Sherin Pathickal, PharmD Candidate c/o 2016 - The mandatory receipt of vaccinations as a preventive public health measure has…

12 years ago

Antipsychotic Use in the Elderly with Dementia

By: Ada Seldin, Staff Editor - The overuse of antipsychotics in the nursing home population for off-label indications continues to…

12 years ago

Evzio™ – New Naloxone Auto-Injector For Opioid Overdose

By: Diana Gritsenko, PharmD Candidate c/o 2015 - Drug overdose is a serious problem in the United States.  In 2010,…

12 years ago

FDA Approves Drug Elosulfase Alfa (Vimizim™) for Mucopolysaccharidosis (MPS IVA)

By: Erica Dimitropoulos Co-Copy Editor [Content- Focused]  - On February 14, 2014, elosulfase alfa (Vimizim™) became an FDA-approved enzyme replacement therapy…

12 years ago

Brown-Bag Event

By: Hayeon Na, Co-Copy Editor (Content Focused) - On February 26th, 2014, pharmacists, clinical faculty, and pharmacy students from St.…

12 years ago

New Strides in Lupus Treatment

By: Daniel Mathan, PharmD Candidate c/o 2016, Anita Kachappilly, PharmD Candidate c/o 2016, & Amrita Singh, PharmD Candidate c/o 2015 -…

12 years ago

Riociguat (Adempas®) New Drug for Pulmonary Hypertension

By: Hayeon Na, Co-Copy Editor [Content-Focused] - On October 8th of 2013, Bayer’s new drug riociguat (Adempas®) was approved for…

12 years ago

Tasimelteon (Hetlioz®): First FDA Approved Pharmacologic Agent for Treatment of Non-24 in Completely Blind Individuals

By: Beatrisa Popovitz, Senior Staff Editor - On January 31st 2014, the FDA announced the release of a revolutionary new…

12 years ago

New Legislation Redefines Oversight for Compounding Pharmacies

By: Davidta Brown, Senior Staff Editor - As the world of healthcare and its provision evolves, laws which organize and…

12 years ago

Prior Experience and the Growth of the Biosimilars Market

By: Davidta Brown, Senior Staff Editor - In 21st century medicine, pharmaceuticals have come to include compounds derived through novel…

12 years ago

Methadone Associated Arrhythmias on the Rise

By: Jenny Park, PharmD Candidate c/o 2015 - Methadone maintenance therapy is prescribed for opioid dependency. Many HIV patients who…

12 years ago

Dietary Supplements and Their Potential Dangers

By: Fatema Elias, Staff Writer - With the New Year and everyone committing to their New Year resolutions, more and…

12 years ago

To Defend the People

By: Davidta Brown, Senior Staff Editor - As the world’s largest market for pharmaceuticals, the United States receives many medications…

12 years ago

New Hepatitis C Drug Receives FDA Approval

By: Ada Seldin, Staff Editor - On November 22, 2013, simeprevir (Olysio®), a new agent to treat chronic hepatitis C,…

12 years ago

Newly Approved: Macitentan (Opsumit®)

By: Rebecca Gilene, PharmD Candidate c/o 2014, St. Louis College of Pharmacy - The FDA approved macitentan (Opsumit®) on October…

13 years ago

Possible Inhaled Option for Diabetics

By: Sang Hyo Kim, Staff Editor - Near the end of December, the pharmaceutical company, MannKind Corp, will submit their…

13 years ago

Ponatinib Taken Off the Market

By: Sherine Jaison, PharmD Candidate c/o 2015 -  The leukemia chemotherapy drug ponatinib (Iclusig) has just been taken off the…

13 years ago

Hospital Drug Shortages

By: Hamid Razaki, PharmD - Drug shortages seen across pharmacies in the United States continue to be an issue in…

13 years ago

Meet the President: An Interview with Father Levesque

By: Beatrice Popovitz, Staff Editor and Ada Seldin, Staff Editor -       In August 2013, St. John’s University welcomed…

13 years ago

Zecuity(TM): Novel Treatment Option for Migraines

By: Arya Mathew, PharmD Candidate c/o 2014 -  About twelve percent of the U.S. population suffers from migraines, affecting adult…

13 years ago

New Treatment for a Deficiency in Iron-Supplement Therapies

By: Davidta Brown, Staff Editor - For the estimated 7.5 million individuals in the United States living with iron deficiency…

13 years ago

New Drug to Treat HIV-1 Hits the Market

By: Ada Seldin, Staff Editor - On August 12,2013, a new weapon against HIV-1 infection was added to the existing…

13 years ago

Ketoconazole No More

By: Hayeon Na, Co-Copy Editor [Content-Focused] - The Food and Drug Administration (FDA) announced on July 26th that oral dosage…

13 years ago

Canagliflozin (Invokana®): New Type 2 Diabetes Drug

By: Sang Hyo Kim, Staff Editor - On March 29th 2013, the U.S Food and Drug Administration approved canagliflozin (Invokana®),…

13 years ago

Nattokinase use in DVT prophylaxis

Samad Tirmizi, Pharm. D. Candidate c/o 2014 - Deep vein thrombosis (DVT) is a clot formation that occurs within deep…

13 years ago

FDA’s New Warning: Acetaminophen Associated with Serious Skin Reactions

By: Andy Zhang, PharmD Candidate c/o 2015 - On August 1st, 2013, the U.S. Food and Drug Administration (FDA) released…

13 years ago

HIV Test: Making a Difference

By: Sang Hyo Kim, Staff Editor - On June 27, 2013, the Centers for Disease Control and Prevention (CDC), AIDS.gov,…

13 years ago

Children, Codeine, and Cytochrome P-450

By Davidta Brown, Staff Editor - For post-operative pain treatment, few drugs are as trustworthy, as tried-and-true, as codeine. Prescriptive…

13 years ago

iPod, iPad, iPhone… iLimb

By: Sang Hyo Kim, Staff Editor - There is a new invention called “i-limb ultra revolution,” which allows amputees to…

13 years ago

New Findings Regarding Cardiovascular Adverse Events with ADHD Medications

By: Aleena Cherian, Co-Copy Editor [Graphics-Focused] - Attention deficit/hyperactivity disorder (ADHD) is a chronic neurological behavior characterized by persistent patterns…

13 years ago

Comparison of the New Oral Antithrombotics and Warfarin

By Omar Khalid Pharm.D. Candidate c/o 2014 - The outpour of a multitude of new oral anticoagulants in recent years…

13 years ago

Two New Agents for the Treatment of Obesity

By: Nathan Trustman, PharmD Candidate c/o 2013, AMSCOP at LIU - Obesity is defined as having a body mass index…

13 years ago

Compounding at a Crossroads: New Boundaries in the Aftermath of Tragedy?

Davidta Brown, PharmD Candidate c/o 2017 -      The debate on the nature of compounding practice and the extent to…

13 years ago

The HIMSS Conference

By: Tina Chang & Helen Dong PharmD Candidates c/o 2014   Ever been to a conference where all you do…

13 years ago

FDA Takes Major Strides Towards Opioid Abuse Prevention

By: Ada Seldin PharmD Candidate c/o 2015 - On April 16th, 2013, the FDA approved the labeling change for the…

13 years ago

Coffeehouse Chats

By: Ada Seldin and Moisey Rafailov, PharmD Candidates Class of 2015 - The “Coffeehouse Chats” is an annual Rho Chi…

13 years ago

Helping Solve the Cruel Mystery

By: Erica Dimitropoulos, Senior Staff Editor - Lupus is highly unpredictable and occurs without warning; there is no known cause…

13 years ago

FDA Approves Dimethyl Fumarate for Treatment of Relapsing Forms of Multiple Sclerosis

By: Andy Zhang, PharmD Candidate c/o 2015 - On March 28, 2013, the U.S. Food and Drug Administration announced the…

13 years ago

Regulation of Low to Moderate Risk Medical Devices by the Food and Drug Administration

By: Hayeon Na, Co-Copy Editor [Content-Focused] - On March 22, 2013, Public Broadcasting Service (PBS) aired an episode of “Need…

13 years ago

College of Pharmacy and Health Sciences Hosts Year-End BBQ Event

By: Tasnima Nabi, Senior Staff Editor - On May 2nd, St. John’s University College of Pharmacy and Health Sciences hosted…

13 years ago

AUVI-Q™: The Newest Epinephrine Device to Hit the Market

By: Diana Gritsenko, Pharm D. Candidate c/o 2015 - Most of us who work in a community pharmacy setting will…

13 years ago

The Honors Program Spotlight

By: Steve Soman - The St. John’s University Honors Program features small classes, faculty mentoring, and an impressive number of…

13 years ago

Flu Season 2012-2013: Rising Opportunities for Pharmacists

By: Fawad Piracha, Pharm. D Candidate c/o 2016 - The 2012-2013 influenza season has developed into one of the greatest…

13 years ago

U.S. v Caronia: Misdemeanor or Constitutional Right?

By: Tamara Yunusova, Staff Editor - On December 3, 2012, the U.S. Second Circuit Court of Appeals became the first…

13 years ago